2012
DOI: 10.1016/j.jtcvs.2011.12.038
|View full text |Cite
|
Sign up to set email alerts
|

Angiotensin-converting enzyme insertion/deletion polymorphism is a risk factor for thoracic aortic aneurysm in patients with bicuspid or tricuspid aortic valves

Abstract: ACE insertion/deletion polymorphism represents a genetic biomarker for TAA. These findings could have a significant effect on both the early detection and effective pharmacologic treatment of aortic disease.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
24
0

Year Published

2012
2012
2019
2019

Publication Types

Select...
9
1

Relationship

0
10

Authors

Journals

citations
Cited by 30 publications
(24 citation statements)
references
References 39 publications
0
24
0
Order By: Relevance
“…Indel polymorphisms of human genes have long been studied to explore their associations with diseases, and several studies suggest that indel polymorphisms may affect gene functions and increase the risk of developing specific diseases (Arinami et al, 1996;Foffa et al, 2012;Zhou et al, 2009). Indel polymorphisms are closely associated with variations in microsatellite regions in several individual PRV genes and, thus, they may be useful as biomarkers to distinguish subgroups.…”
Section: Discussionmentioning
confidence: 99%
“…Indel polymorphisms of human genes have long been studied to explore their associations with diseases, and several studies suggest that indel polymorphisms may affect gene functions and increase the risk of developing specific diseases (Arinami et al, 1996;Foffa et al, 2012;Zhou et al, 2009). Indel polymorphisms are closely associated with variations in microsatellite regions in several individual PRV genes and, thus, they may be useful as biomarkers to distinguish subgroups.…”
Section: Discussionmentioning
confidence: 99%
“…Finally, multiple other common genetic variants [e.g., angiotensin-converting enzyme (ACE) and matrix metalloproteinase (MMP) polymorphisms] may act as modifier genes in the pathogenesis of BAV aortopathy, contributing to the variability of clinical phenotypes (42,43).…”
Section: Aortic Dilatation: Intrinsic or Induced Development?mentioning
confidence: 99%
“…78 Associations have also been reported between aneurysm risks in BAV patients with polymorphisms in eNOS, angiotensin I-converting enzyme, and MMP-9 and MMP-2 genes. 79,80 Furthermore, downregulation of the ubiquitin fusion degradation 1-like gene, which is highly expressed in the cardiac outflow tract during embryogenesis, has also been noted in BAV, and may represent a candidate gene. 81 In addition to the above studies in humans, animal studies have shed light on the genetic basis of BAV.…”
mentioning
confidence: 99%